PROPYLTHIOURACIL
Generic: PROPYLTHIOURACIL
Chartwell RXManufacturer
ORALRoute
PROPYLTHIOURACILActive Substance
1970-07-24Original Approval
PROPYLTHIOURACIL is FDA application ANDA080016, sponsored by CHARTWELL MOLECULAR. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
197 reports
2
OFF LABEL USE
152 reports
3
HYPERTHYROIDISM
138 reports
4
FOETAL EXPOSURE DURING PREGNANCY
117 reports
5
NAUSEA
87 reports
6
ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS
86 reports
7
EXPOSURE DURING PREGNANCY
85 reports
8
MATERNAL EXPOSURE DURING PREGNANCY
76 reports
9
HYPOTENSION
70 reports
10
AGRANULOCYTOSIS
60 reports